Cargando…

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan

PURPOSE: Cultural differences are hypothesized to influence patients’ Quality of Life (QoL) reports. However, there is a lack of empirical cross-cultural studies comparing QoL of patients with cancer. This study aims to compare QoL of women with breast cancer in the Netherlands and Japan, and to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, M. J., Inoue, K., Matsuda, A., Kroep, J. R., Nagai, S., Tozuka, K., Momiyama, M., Weijl, N. I., Langemeijer-Bosman, D., Ramai, S. R. S., Nortier, J. W. R., Putter, H., Yamaoka, K., Kubota, K., Kobayashi, K., Kaptein, A. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668344/ https://www.ncbi.nlm.nih.gov/pubmed/28762012 http://dx.doi.org/10.1007/s10549-017-4417-z

Ejemplares similares

Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancer
por: Lugtenberg, R. T., et al.
Publicado: (2020)

Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study
por: Vollmann, Manja, et al.
Publicado: (2020)

Effects of a Self-Monitoring Quality of Life Intervention in Outpatients with Breast Cancer: A Preliminary Report of A Randomized Controlled Trial
por: Matsuda, Ayako, et al.
Publicado: (2022)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer
por: Blok, Erik J., et al.
Publicado: (2017)

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, S., et al.
Publicado: (2015)

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
por: Dezentjé, V. O., et al.
Publicado: (2015)

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
por: van Nes, J. G. H., et al.
Publicado: (2012)

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials
por: Kroep, J.R., et al.
Publicado: (2015)

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial
por: Lugtenberg, Rieneke T., et al.
Publicado: (2020)

Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands
por: Walstra, Coco J. E. F., et al.
Publicado: (2021)

Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique
por: van Boekel, G. A. J., et al.
Publicado: (2015)

Combination Therapy With Zoledronic Acid and FES‐Row Training Mitigates Bone Loss in Paralyzed Legs: Results of a Randomized Comparative Clinical Trial
por: Morse, L R, et al.
Publicado: (2019)

Mammographic screening detects low-risk tumor biology breast cancers
por: Drukker, C. A., et al.
Publicado: (2014)

Self Help Plus: study protocol for a cluster-randomised controlled trial of guided self-help with South Sudanese refugee women in Uganda
por: Brown, F. L., et al.
Publicado: (2018)

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
por: Rugo, H. S., et al.
Publicado: (2019)

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020)

Cluster‐randomized crossover trial of chlorhexidine–alcohol versus iodine–alcohol for prevention of surgical‐site infection (SKINFECT trial)
por: Charehbili, A., et al.
Publicado: (2019)

Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
por: Lemij, Annelieke A., et al.
Publicado: (2022)

Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
por: Dilawari, A., et al.
Publicado: (2021)

Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study
por: Krajnak, S., et al.
Publicado: (2020)

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
por: Hennigs, A., et al.
Publicado: (2016)

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
por: Zambrowicz, B, et al.
Publicado: (2012)

The frequency of missed breast cancers in women participating in a high-risk MRI screening program
por: Vreemann, S., et al.
Publicado: (2018)

Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
por: Yu, Y. F., et al.
Publicado: (2017)

Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial
por: Lipplaa, Astrid, et al.
Publicado: (2019)

To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
por: Herbert, S. L., et al.
Publicado: (2020)

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
por: Mostafid, A. Hugh, et al.
Publicado: (2020)

Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices
por: Wyld, L, et al.
Publicado: (2021)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer
por: Helbrich, H., et al.
Publicado: (2021)

EndoPredict(®) in early hormone receptor-positive, HER2-negative breast cancer
por: Almstedt, K., et al.
Publicado: (2020)

Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and Monitoring
por: Stewart, J., et al.
Publicado: (2015)

Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
por: Martín, M., et al.
Publicado: (2018)

Rationale and design of a smartphone‐enabled, home‐based exercise program in patients with symptomatic peripheral arterial disease: The smart step randomized trial
por: Harzand, Arash, et al.
Publicado: (2020)

Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery
por: Sultan, J, et al.
Publicado: (2012)

Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST‐Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design
por: Bulluck, Heerajnarain, et al.
Publicado: (2015)

Illness Perceptions in Women with Breast Cancer—a Systematic Literature Review
por: Kaptein, Ad A., et al.
Publicado: (2015)

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
por: McMurray, John J.V., et al.
Publicado: (2013)

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g210ug5af8d9sbcavf3gdapv1t